As of Aug 22
| +0.10 / +0.54%|
The 12 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 18.50, with a high estimate of 21.00 and a low estimate of 12.00. The median estimate represents a -0.27% decrease from the last price of 18.55.
The current consensus among 13 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.